Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. N-(8-(2-hydroxybenzoyl)amino)caprylate
2. N-(8-(2-hydroxybenzoyl)amino)caprylate Sodium
3. N-snac
4. Snac Sodium
5. Sodium N-(8-(2-hydroxybenzoyl)amino)caprylate
1. 203787-91-1
2. Snac
3. Sodium 8-(2-hydroxybenzamido)octanoate
4. E414
5. Salcaprozate Sodium [usan]
6. Sodium;8-[(2-hydroxybenzoyl)amino]octanoate
7. Octanoic Acid, 8-[(2-hydroxybenzoyl)amino]-, Monosodium Salt
8. Salcaprozate (sodium)
9. Sodium,8-[(2-hydroxybenzoyl)amino]octanoate
10. 1ytw0422yu
11. Sodium 8-[(2-hydroxybenzoyl)amino]octanoate
12. E-414
13. Sodium 8-((2-hydroxybenzoyl)amino)octanoate
14. Salcaprozate Sodium (usan)
15. Octanoic Acid, 8-((2-hydroxybenzoyl)amino)-, Monosodium Salt
16. Sodium Salcaprozate
17. Unii-1ytw0422yu
18. Salcaprozic Acid, Sodium Salt
19. E 414
20. Salcaprozate Sodium, 99%
21. Salcaprozic Acid Sodium Salt
22. Schembl825599
23. Chembl2107027
24. Dtxsid50174306
25. Amy24031
26. Ex-a3434
27. Mfcd00952954
28. Sodium8-(2-hydroxybenzamido)octanoate
29. Ac-31357
30. As-65676
31. P414
32. Hy-114299
33. Cs-0081977
34. Ft-0696582
35. D05787
36. I10998
37. A879665
38. Q27253228
39. Sodium 8-[(2-hydroxyphenyl)formamido]octanoate
40. Octanoic Acid, 8-[(2-hydroxybenzoyl)amino]-, Sodium Salt
41. Sodium,8-[(2-hydroxybenzoyl)amino]octanoate;sodium 8-(2-hydroxybenzamido)octanoate
Molecular Weight | 301.31 g/mol |
---|---|
Molecular Formula | C15H20NNaO4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 9 |
Exact Mass | 301.12900240 g/mol |
Monoisotopic Mass | 301.12900240 g/mol |
Topological Polar Surface Area | 89.5 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 312 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40217
Submission : 2024-07-22
Status : Active
Type : IV
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38202
Submission : 2023-03-31
Status : Active
Type : IV
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41533
Submission : 2025-03-15
Status : Active
Type : IV
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40217
Submission : 2024-07-22
Status : Active
Type : IV
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38202
Submission : 2023-03-31
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39618
Submission : 2024-10-10
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41533
Submission : 2025-03-15
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39651
Submission : 2024-03-14
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40767
Submission : 2024-11-11
Status : Active
Type : IV
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41615
Submission : 2025-03-28
Status : Active
Type : IV
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40177
Submission : 2024-07-16
Status : Active
Type : IV
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40147
Submission : 2024-06-27
Status : Active
Type : IV
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 76339-505
Start Marketing Date : 2023-11-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (19.999kg/19.999kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 76339-179
Start Marketing Date : 2022-11-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (19.999kg/19.999kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 73212-066
Start Marketing Date : 2023-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42571-541
Start Marketing Date : 2025-06-12
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71666-012
Start Marketing Date : 2021-03-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84536-378
Start Marketing Date : 2025-01-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
About the Company : Ami Lifesciences, established in 2006, is one of the fastest growing API manufacturing companies in India. Specializing in cardiovascular, anti-diabetic, CNS, and respiratory thera...
Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
About the Company : Established in 2004 and headquartered in Hangzhou, Hengkang established multiple factories, research and sales centers in Zhejiang, Shandong, and Henan. With facilities conforming ...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
About the Company : Omgene Life Sciences Private Limited is an R&D-driven biopharmaceutical company specializing in biopharmaceuticals, peptides, semi-synthetic, and synthetic actives. As a vertically...
About the Company : Beijing Mesochem Technology Co. Ltd., which is located in the national economic and technological development area of Yizhuang, China, manufactures pharmaceutical chemicals, fine c...
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
About the Company : Honour is a leading global CDMO and a trusted manufacturer of specialty chemicals and ingredients. With seven world-class facilities built to meet global safety and quality standar...
About the Company : CongenPharma, founded in 2013 and headquartered in Guangzhou, is a leading manufacturer of pharmaceutical peptide intermediates, cosmetic peptides, and ingredients. With our propri...
About the Company : Sinopep leads the industry in therapeutic peptides, supplying top-demand APIs like Albuvirtide, Lanreotide, Semaglutide, and more. Renowned for high-quality peptide APIs and effici...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
Reply
27 Jun 2025
Reply
11 Feb 2025
Reply
01 Apr 2024
Reply
30 Jul 2022
Reply
08 Jul 2022
ABOUT THIS PAGE
12
PharmaCompass offers a list of Salcaprozate Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Salcaprozate Sodium manufacturer or Salcaprozate Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Salcaprozate Sodium manufacturer or Salcaprozate Sodium supplier.
PharmaCompass also assists you with knowing the Salcaprozate Sodium API Price utilized in the formulation of products. Salcaprozate Sodium API Price is not always fixed or binding as the Salcaprozate Sodium Price is obtained through a variety of data sources. The Salcaprozate Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Salcaprozic acid sodium salt manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Salcaprozic acid sodium salt, including repackagers and relabelers. The FDA regulates Salcaprozic acid sodium salt manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Salcaprozic acid sodium salt API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Salcaprozic acid sodium salt manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Salcaprozic acid sodium salt supplier is an individual or a company that provides Salcaprozic acid sodium salt active pharmaceutical ingredient (API) or Salcaprozic acid sodium salt finished formulations upon request. The Salcaprozic acid sodium salt suppliers may include Salcaprozic acid sodium salt API manufacturers, exporters, distributors and traders.
click here to find a list of Salcaprozic acid sodium salt suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Salcaprozic acid sodium salt DMF (Drug Master File) is a document detailing the whole manufacturing process of Salcaprozic acid sodium salt active pharmaceutical ingredient (API) in detail. Different forms of Salcaprozic acid sodium salt DMFs exist exist since differing nations have different regulations, such as Salcaprozic acid sodium salt USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Salcaprozic acid sodium salt DMF submitted to regulatory agencies in the US is known as a USDMF. Salcaprozic acid sodium salt USDMF includes data on Salcaprozic acid sodium salt's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Salcaprozic acid sodium salt USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Salcaprozic acid sodium salt suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Salcaprozic acid sodium salt as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Salcaprozic acid sodium salt API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Salcaprozic acid sodium salt as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Salcaprozic acid sodium salt and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Salcaprozic acid sodium salt NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Salcaprozic acid sodium salt suppliers with NDC on PharmaCompass.
Salcaprozic acid sodium salt Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Salcaprozic acid sodium salt GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Salcaprozic acid sodium salt GMP manufacturer or Salcaprozic acid sodium salt GMP API supplier for your needs.
A Salcaprozic acid sodium salt CoA (Certificate of Analysis) is a formal document that attests to Salcaprozic acid sodium salt's compliance with Salcaprozic acid sodium salt specifications and serves as a tool for batch-level quality control.
Salcaprozic acid sodium salt CoA mostly includes findings from lab analyses of a specific batch. For each Salcaprozic acid sodium salt CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Salcaprozic acid sodium salt may be tested according to a variety of international standards, such as European Pharmacopoeia (Salcaprozic acid sodium salt EP), Salcaprozic acid sodium salt JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Salcaprozic acid sodium salt USP).